Twist Bioscience (TWST) Operating Income: 2018-2025
Historic Operating Income for Twist Bioscience (TWST) over the last 8 years, with Sep 2025 value amounting to -$29.9 million.
- Twist Bioscience's Operating Income rose 16.95% to -$29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$136.3 million, marking a year-over-year increase of 38.30%. This contributed to the annual value of -$136.3 million for FY2025, which is 38.30% up from last year.
- According to the latest figures from Q3 2025, Twist Bioscience's Operating Income is -$29.9 million, which was up 0.62% from -$30.1 million recorded in Q2 2025.
- Twist Bioscience's 5-year Operating Income high stood at -$29.9 million for Q3 2025, and its period low was -$88.9 million during Q2 2024.
- In the last 3 years, Twist Bioscience's Operating Income had a median value of -$47.0 million in 2023 and averaged -$48.1 million.
- Its Operating Income has fluctuated over the past 5 years, first tumbled by 70.59% in 2021, then skyrocketed by 66.13% in 2025.
- Twist Bioscience's Operating Income (Quarterly) stood at -$55.9 million in 2021, then grew by 20.22% to -$44.6 million in 2022, then dropped by 5.26% to -$47.0 million in 2023, then rose by 26.25% to -$34.6 million in 2024, then rose by 16.95% to -$29.9 million in 2025.
- Its last three reported values are -$29.9 million in Q3 2025, -$30.1 million for Q2 2025, and -$41.6 million during Q1 2025.